Our clinical pipeline features targeted therapeutic applications and clinical development in three primary therapeutic domains. More details on specific clinical trials can be found HERE.
The osteoarthritis trial is a Phase 3 multi-site pivotal clinical trial that is double-blinded, randomized, placebo-controlled, dose-escalated, and statistically powered. The study has been completed. Trial has IDE and is compliant with FDA regulations.
Human data in development – pilot
A study describing advancements that injectable carriers, tissue grafts, anisotropically oriented biomaterials, and cell sheets have achieved in preclinical models as stem cell carriers for tendon repair.
https://pubmed.ncbi.nlm.nih.gov/26238455/
A study evaluating the safety of adipose-derived SVF for intra-articular injection of the knee and the feasibility of an intra-articular injection for pain relief in osteoarthritic knees.
https://stemcellres.biomedcentral.com/articles/10.1186/scrt426
A study evaluating the safety of intra-articular injection of SVF and the feasibility for reduction of pain in osteoarthritic knees.
https://drdumanian.com/wp-content/uploads/2015/06/stem_cells_for_arthritis.pdf
A study examining the effects of adipose-derived, stem cell-conditioned medium on alopecia.
https://cms.galenos.com.tr/Uploads/Article_42644/jtad-14-107-En.pdf
A study examining the use of stromal and vascular cells for the treatment of diabetic foot ulcers (peripheral vascular disease).
https://pubmed.ncbi.nlm.nih.gov/24691309/
A study examining the effect and possible mechanism of adipose-derived stem cell-conditioned medium on hypertrophic scars.
https://stemcellres.biomedcentral.com/articles/10.1186/s13287-016-0356-6
A summary and review of the proliferation and capacity of adipose-derived stem cells as a regenerative tool in plastic and reconstructive surgery.
A clinical trial for safety and feasibility examining the use of stromal vascular cells for the treatment of erectile dysfunction.
https://pubmed.ncbi.nlm.nih.gov/29960873/
A clinical trial for safety and feasibility examining the use of stromal vascular cells for the treatment of COPD.
